Stair Climbing Power Wheelchair with FDA Certification for Safety

Name: Stair Climbing Power Wheelchair with FDA Certification for Safety
Brand: Jiangsu Jumao X-Care Medical Equipment Co., Ltd.
SKU: 2147171875

Jiangsu, ChinaJiangsu Jumao X-Care Medical Equipment Co., Ltd.

US$440.00-455.00

50 Pieces

Sample price:US$470.00/piece.Request sample

Product profile

Customization

Available

Customized

Certification

ISO, RoHS, CE

Model NO.

JM-PW033-8W RW003

Condition

New

Tilted

Non-Tilted

Folded

Non-Folding

Leg Rest Type

Both Sides Separate

Material

Steel

Type

Electric Wheelchair

Motor Power

500W

Color

Black&Red

Battery

Lead Acid Battery

Rated Voltage

24V

Transport Package

Carton

Specification

860*565*820 mm

Trademark

JUMAO

Origin

China

HS Code

8713100000

Production Capacity

500000/Year

Company profile

Importers and ExportersSelf-brandedR&D CapabilitiesManagement Certification

Jiangsu Jumao X-Care Medical Equipment Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 6 years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤1.85h

AI-Powered supplier vetting

SummaryThe supplier is identified as a combined company specializing in rehabilitation and healthcare products, including wheelchairs, rollators, oxygen concentrators, and patient beds. It reports documented procedures for corrective and preventive actions, customer complaints, design review, and finished-product inspection. The supplier provides OEM and ODM services, supports multiple forms of customization, and has reported new products within the past year. Production-related evidence includes multiple processing and assembly capabilities, inventory capacity, and quality assurance, but there is no valid manufacturing-capacity contract with affiliated subcontractors. Overseas support is limited: the supplier has no overseas warehouse, showroom, agents, or branches, although it has attended MEDICA and reports service coverage in 11 countries. Certification holdings are not explicitly provided. Financial credibility cannot be assessed from the available non-financial evidence.

Supplier typeThe supplier is classified as a combined company and operates in medical and rehabilitation product manufacturing, with stated expertise in wheelchairs, rollators, oxygen concentrators, patient beds, and related healthcare products.

After-Sales capabilityThe supplier has documented and followed procedures for corrective and preventive actions and customer complaints, and its technical engineers provide technical support for production and after-sales service. However, it has no overseas agents or branches, which limits evidence of local overseas support.

R&D capabilityThe supplier reports new products within the past year, dedicated R&D teams in China and the United States, documented design input/output, review, verification, and validation records, and ODM capability. It does not provide 3D software design services or an available SDK, but these limitations do not negate the broader evidence of R&D activity.

Production capacityProduction evidence includes multiple processing and assembly capabilities, quality assurance, standardized finished-product inspection instructions, inventory capacity, and regulated medical-device production scope. A stated deficiency is the absence of a valid contract between the factory and affiliated subcontractors, creating a documented manufacturing-governance gap.

Customization capabilityThe supplier explicitly supports customization from samples, customization from designs, full customization, minor customization, and flexible customization. This is supported by both its R&D service description and design-services capability listing.

Client casesThe supplier has participated in the MEDICA offline trade show, reports that governments and foundations have designated its products for medical institutions, and states that it provides overseas services in 11 countries. These references indicate institutional and international market exposure, although named customer cases are not provided.